Neurodegeneration – News and Features

This round will enable the company to accelerate the development of its antifungal compounds.

Progress made toward developing next generation molecular medicines to treat obesity and type 2 diabetes.

The researchers show how people's genes play a role in their response to stress in their environment.

Roche and MorphoSys will collaborate on two new antibody programs in oncology.

British researchers identified variations in SRY gene levels may be linked to the onset of Parkinson's.

Ichor has granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.

The consortium represents an avenue for collaborative interactions among researchers and institutional leaders from the three universities.

President’s FY07 budget calls for $40 million a year boost for multi-year effort.

Both Companies have announced license agreement for the development of a humanized monoclonal antibody 'MNAC13'.

Researchers in North America, Europe, and Asia outsource comprehensive gene expression analysis using ABI's Expression Array system.